1. MacDougal C Penicillins, cephalosporin, and other β-lactam antibiotics. In: Brunton Hilal-dandan LL, Knollmann BC, editors. The Goodman & Gilman’s: The Pharmacological Basis of the Therapeutics. 13th ed. New York: McGraw Hill; 2018. p. 1023-38.
2. Young BC, Dunsmure L, Downs L, Kildonaviciute K, Jones N Cefazolin as second line treatment for invasive methicillin-susceptible Staphylococcus aureus infection in a UK cohort of patients. J Infect 2021;82:e25-7.
3. Eljaaly K, Alshehri S, Erstad BL Systematic review and meta-analysis of the safety of antistaphylococcal penicillins compared to cefazolin. Antimicrob Agents Chemother 2018;62:e01816-e1817.
4. Efficacy and safety of cefazolin versus antistaphylococcal penicillins for the treatment of methicillin-susceptible Staphylococcus aureus bacteremia: A systematic review and meta-analysis;Shi;BMC Infect Dis,2018
5. Nicolau DP, Silberg BN Cefazolin potency against methicillin-resistant Staphylococcus aureus: A microbiologic assessment in support of a novel drug delivery system for skin and skin structure infections. Infect Drug Resist 2017;10:227-30.